Mylan Makes $29B Bid To Buy Pharma Co. Perrigo
Mylan Pharmaceuticals Inc. has offered to acquire fellow pharma player Perrigo Co. PLC for $205 per share, in a deal that would value the Irish maker of over-the-counter drugs and health...To view the full article, register now.
Already a subscriber? Click here to view full article